Se
Severance Hospital
NPSeoul KRFounded 18855,000 employees
Private CapacadPrivateOncologyHematology
Platform: Yonsei Med
Market Cap
N/A
All Drugs
7
Clinical Trials
7
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (7 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| SEV-IIT-582 | SEV-IIT-582 | Preclinical | 1 | CFTR | Crohn's | ||
| SEV-IIT-392 | SEV-IIT-392 | NDA/BLA | 1 | CGRP | Atopic Derm | ||
| SEV-IIT-475 | SEV-IIT-475 | Approved | 1 | AuroraA | LGS | ||
| SEV-IIT-977 | SEV-IIT-977 | Phase 3 | 1 | PD-1 | Cervical Ca | ||
| SEV-IIT-334 | SEV-IIT-334 | Phase 1 | 1 | CD19 | HNSCC | ||
| SEV-IIT-593 | SEV-IIT-593 | Phase 1 | 1 | TNFα | Ovarian Ca | ||
| SEV-IIT-824 | SEV-IIT-824 | Phase 2 | 1 | PARP | SCD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (8)